HLB Biostep Co., Ltd. (278650)

Overview

HLB bioStep Co., Ltd. is a comprehensive service provider specializing in various test services for the biotechnology and pharmaceutical industries. Initially established as KNOTUS Co.,Ltd., the company underwent a rebranding to better reflect its expanded capabilities and global outreach. Founded in 2012 and headquartered in Incheon, South Korea, HLB bioStep has positioned itself as a key partner in the development of biopharmaceuticals, offering a wide range of analytical and research services. The company employs platform technology to deliver accurate, reliable testing services, supporting its clients from the early stages of drug discovery through to the pre-clinical and clinical phases of development.

Products and Services

HLB bioStep Co.,Ltd. extends its expertise across multiple areas, ensuring comprehensive support for the biotechnology and pharmaceutical sectors:

• Cell-Enzyme-Based Screening: Utilization of cell and enzyme assays for the identification of promising compounds in drug development.
• Xenograft Assay: Evaluation of the efficacy of anti-cancer drugs in live models through the implementation of tumor xenografts.
• Mitogenic Effect Test: Assessment of the potential cell division triggering effects of substances.
• Vaccine Antigen, Antibody Titration: Quantification of vaccine antigen potency and antibody levels in serum.
• Cytokine, mRNA Expression: Analysis of cytokine levels and gene expression to assess immune responses.
• Trachea Relaxation Assay: Evaluation of substances for their potential bronchodilatory effects.
• Carrageenan, Adjuvant Induced Paw Edema: Investigation of anti-inflammatory properties of compounds in induced edema models.
• Antipyretic, Anti-Pain Test: Examination of compounds for fever reduction and analgesic properties.
• Isolated Blood Vessel Screening: Study of vascular effects of pharmaceutical agents in isolated blood vessel preparations.
• Fibrin Plate Lysis Screening: Assessment of fibrinolytic activity of substances, important for dissolving blood clots.
• Ferric Chloride Induced Model: Model for studying thrombosis and the effectiveness of anti-thrombotic agents.
• Food Diet Induced Model: Investigation of the impacts of dietary components on health and disease models.
• Gastric Acid Secretion: Measurement of gastric acid secretion to assess potential gastrointestinal effects of compounds.
• Emesis Model: Evaluation of anti-emetic potential of drugs in models of induced vomiting.
• MIC Test: Determination of the minimum inhibitory concentration of antimicrobial agents against bacteria.
• Post Antibody Effect: Study of the lasting impact of antibody treatments.
• Enzyme Assay: Quantitative measurement of enzymatic activity in biological samples.
• Systemic, Local Infection Model: Development and utilization of infection models for the assessment of anti-infective agents.
• PK Study: Pharmacokinetic studies to analyze how drugs move through the body over time.
• Chemical, Transgenic Animal: Utilization of chemically induced and genetically modified animal models for research.
• Osteoblast-Like Cell Line Screening: Screening compounds for potential effects on bone cell lines, relevant for bone health research.
• Bone Formation Marker: Assessment of markers indicative of bone formation in response to treatments.
• Biomarker: Identification and analysis of biomarkers for diagnostic, prognostic, and therapeutic purposes.
• Pharmacokinetic/Toxico Study: Comprehensive studies on the kinetic behavior of drugs and their toxicological profiles.
• Toxicology Study: Detailed analysis of the potential toxic effects of substances on biological systems.
• Toxic/Clinical Pathology Services: Specialized pathology services to support toxicology and clinical studies.